CLINICAL EVALUATION OF A NEW RESERPINE DERIVATIVE, SU-3118 (SYROSINGOPINE).

Autor: Kert, Morley J., Mailman, Richard H., Roth, Samuel J., Witherbee, Harold, Avedon, Melvin
Předmět:
Zdroj: Angiology; Feb1960 Part 1, Vol. 11 Issue 1, p31-34, 4p
Abstrakt: SU-3118 was administered to ,56, principally male, outpatient hypertensives and was found to have significant, albeit on the average slight, antihypertensive action in approximately two-fifths of patients in doses up to 12 mg daily. About two-fifths of reserpine responders were noted to respond to this drug and side effects were about one-third to one-half as frequent with SU-3118 as with reserpine, SU-3118 appears to be less than one-seventh as potent as its parent drug. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index